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1. Introduction 
The macromolecule which, in the subsynaptic 
membrane, carries the physiological receptor site for 
acetylcholine (ACh), the acetylcholine receptor 
protein (AChR), is a rather well characterized macro- 
molecule (reviewed [ 1,2] ). Yet, the identity of the 
ion gate, or ionophore [3], which is under its 
command remains to be established without ambiguity. 
In particular, is the ACh-ionophore part of the puri- 
fied receptor protein or, on the opposite, an entirely 
distinct macromolecule, highly coupled with the 
receptor protein in the subsynaptic membrane in situ? 
One evident approach to answer this question is to 
try to ‘reconstitute’ the permeability response to 
ACh starting from well defined components of the 
subsynaptic membrane dispersed into solution 
(reviewed [4] ). The experiment appears feasible 
[S-7] but its rather low reproducibility suggests 
that some basic elements of the system yet are not 
under control. Another approach is based on the 
labeling of the ACh-ionophore by characteristic 
ligands followed by the identification and characteri- 
zation of the macromolecule to which they bind. 
Electrophysiological evidence indicates that the 
amine local anesthetics, like prilocaine or quotane 
Abbreviations: C,DAChol, { l-(5dimethylaminonaphthalene) 
sulfonamido ) n-hexanoic acid P-(N-trimethylammonium 
bromide) ethyl ester; Trimethisoquin, l-(p-trimethylamino- 
ethoxy) 3-n-butylisoquinoline hydrochloride 
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(refs. in [I] ), and the frog toxin, histrionicotoxin 
[8-lo] , interact with the ACh-ionophore and are 
potential labels of this structural entity. 
Interestingly, these compounds behave, in vitro, 
as allosteric effecters of the AChR-site in AChR-rich 
membrane fragments purified from Tolpedo electric 
organ [ 11,121, Moreover, this interaction is lost when 
the membrane fragments are solubilized by detergents 
[ 11,13,14] . Finally, a protein which binds histrionico- 
toxin and the fluorescent local anesthetic, quinacrine, 
has been isolated from the same fragments [ 151. In 
many respects, it differs from the AChR-protein. In 
particular, by electrophoresis in denaturing poly- 
acrylamide gels it gives a single band of app. mol. wt 
43 000 distinct from the mol. wt 40 000 band given 
by the purified AChR-protein. 
In order to understand the functional significance 
of this ‘43 k protein’, we attempted, first, to recover 
the allosteric interaction between AChR-site and local 
anesthetic binding site starting from a crude detergent 
soluble extract of AChR-rich membranes containing 
both the AChR and the 43 k protein in a soluble 
form. A convenient method to follow the recovery of 
this interaction is to record the effect of local anes- 
thetics on the fast kinetic of interaction of a fluo- 
rescent choline& agonist &DAChol [16-191 with 
the AChR-rich membrane fragments. In this letter we 
report that, when the concentration of detergent is 
lowered by dilution [ 131, the effect of local anes- 
thetics on the kinetics of interaction of CsDAChol 
with the AChR-site can, indeed, be ‘reconstituted’. 
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2. Materials and methods 
2.1. Preparation of AChR-rich membrane fragments 
The AChR-rich membrane fragments were prepared 
by the method in [20] from freshly dissected electric 
tissue from Torpedo marmorata, and stored at -195°C 
in bidistilled water containing 0.1 mM phenylmethyl- 
sulfonyl fluoride (a protease inhibitor) and 0.02% 
NaN3. 
The concentration of AChR-sites was measured 
with Naja nigricollis 01- [3H]toxin (12.4 Ci/mmol) 
by ultracentrifugation [21] . Proteins was estimated 
by the method in [22] using bovine serum albumin 
as standard. The specific activity of the preparations 
used ranged from 1500-3000 nmol a-toxin binding 
sites/g protein. 
2.2. Solubilization of the membrane fragments by 
Na-cholate 
The membrane fragments were solubilized by the 
method in [20] for the purification of the ACh 
receptor, with the following modifications: 0.5 ml 
concentrated suspension of membrane fragments in 
bidistilled water (30-50 PM a-toxin binding sites, 
20 mg protein/ml) supplemented with 30 mM 
2-mercaptoethanol was mixed with an equal volume 
of a solution of 10% (w/v) Na cholate, 200 mM NaCl, 
30 mM 2-mercaptoethanol and 10 mM Na phosphate 
buffer (pH 7.0) in bidistilled water and stirred for 
30-45 s; the mixture was then diluted S-fold into a 
modified Torpedo physiological saline solution 
(250 mM NaCl, 5 mM KCl, 5 mM Na phosphate buffer 
(pH 7.0)) to a final cholate concentration of 1%. The 
solution (5 ml) was then centrifuged in a 10 ml tube 
at 4°C for 30 min in a Beckman rotor 40 at 33 000 
rev./min (-100 000 X g) and the supernatant collected. 
2.3. Stopped-jlow experiments 
Rapid kinetic experiments were carried out in a 
Gibson-Durrum stopped-flow rapid mixing apparatus 
equipped for fluorescence detection. Fluorescence 
was excited at 290 nm using a 450 W Osram Xenon 
lamp and a grating monochromator (Jobin Yvon 
HRS 2); 90” fluorescence in the observation cell 
(quartz tube 2 mm diam. and 18 mm length) was 
monitored with an Hamamatsu R 376 photomulti- 
plier using a high pass filter (540 nm cut). Single sliot 
fluorescence signals were digitally stored in a Tracer 
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NS 570 (12 bits 1024 points) and plotted with a 
X-Y recorder. The traces were analysed with a X-Y 
Numonics graphic analyser on line with a Wang 2200 
computer to which were given from 20-30 points/ 
curve; the experimental traces were fitted using a non- 
linear iterative regression program (least square fit 
criterion) by mono- or multi-exponentials, and both 
amplitudes and rate constants determin’ed. 
2.4. Polyacrylamide gel electrophoresis 
Polyacrylamide gel electrophoresis in the presence 
of sodium dodecyl sulfate was performed as in [20] 
on 1.1 mm thick, 10% acrylamide slab gels by the 
method in [23] as modified [24]. Destained gels 
were scanned with a Vernon gel scanner. 
2.5. Chemicals 
GDAChol was a gift of Dr G. Waksman, M. C. 
FourniB-Zaluski and B. Roques who synthesized it; 
the details of the procedure for synthesis are given in 
Dbl. 
The purified a-toxin from N. nigricollis was a gift 
of Dr P. Boquet and was tritiated by Drs A. Menez, 
J. Morgat and P. Fromageot; prilocaine hydrochloride 
and trimethisoquin (1 -@-trirnethylaminoethoxy) 
3-n-butylisoquinoline hydrochloride) were a gift from 
the Laboratoire Roger Bellon (France); Na cholate 
(analytical grade) was from Merck. 
3. Results 
3.1. Solubilization of the AChR-rich membranes by 
Na cholate 
AChR-rich membrane fragments (spec. act. 
1500-3000 nmol a-toxin sites/g protein) were first 
solubilized in 5% Na cholate, then diluted to 1% 
cholate, and finally centrifuged at 100 000 X g for 
30 min yielding the 1% cholate-soluble extract 
(see section 2). Under these conditions, -90% of the 
01- [3H] toxin binding sites remain in the supernatant. 
The initial crude extract and the supernatant were 
submitted to unidimensional polyacrylamide gel 
electrophoresis in the presence of sodium dodecyl 
sulfate following the procedure in [24] (see section 2). 
As reported [ 15,201, two major protein bands are 
observed in the uncentrifuged crude extract of the 
AChR-rich membranes (fig.1). Their app. mol. wt are 
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Fig.1. Polyacrylamide gel electrophoresis in the presence of 
sodium dodecyl sulfate of (a) AChR-rich membrane fragments 
solubilized in cholate and (b) the same extract after 30 mm 
centrifugation at 100 000 X g (cholate-soluble xtract) (see 
section 2). Densitometric scan of the gel stained with 
Coomassie brilliant blue. T.D., tracking dye; the numbers 
above the bands indicate the apparent molecular weights 
(X 10m3) of the corresponding polypeptide chains. Aliquots, 
15 ~1, of solubilized membrane fragments rich in AChR 
(-4 PM a-toxin binding sites, 2.7 mg protein/ml, 1% cholate) 
were pipetted before (a) and after (b) centrifugation at 
100 000 X g, incubated for 1 min at 100°C with equal 
volumes of a solution of 2% sodium dodecyl sulfate, 0.065 M 
Tris-HCl (pH 6.8), 10% glycerol and 1% 2-mercapthoethanol, 
and submitted to electrophoresis on a 10% acrylamide gel; 
the electrophoresis was carried out at a constant current of 
30 mA for 3-4 h and the gel fixed in 25% isopropanol/lO% 
acetic acid/65% water for 1 h, stained overnight with 0.25% 
Coomassie brilliant blue in the same medium and destained 
with the fixation medium. 
40 000 f 1000 and 43 000 + 1000. Densitometric 
scan of the gels stained with Coomassie blue shows 
that these bands are present in almost equal amounts. 
After high speed centrifugation and with some 
preparations of membrane fragments most of the 
43 000 mol. wt band is recovered in the pellet [ 151; 
with the membrane preparations used in this work, 
-90% of the 40 000 mol. wt and 50% of the 
43 000 mol. wt bands remain in the supernatant after 
centrifugation. 
Centrifugation of the cholate extract on a 5-20% 
(w/v) sucrose gradient gives a single and symmetrical 
peak of a-[3H]toxin-binding material with a standard 
sedimentation coefficient of 9 S characteristic of the 
soluble form of the AChR protein and the 43 k 
protein does not comigrate with it (A. S., unpublished 
results). 
The 1% cholate-soluble extract, therefore, contains 
the AChR-protein and other components of the 
AChR-rich membranes, such as the 43 k protein, 
in a dispersed and soluble form. 
3.2. Interaction of CsDAChol with the AChR-site in 
the 1% cholate-soluble extract 
It was shown [ 171 that rapid mixing of AChR- 
rich membrane fragments with CsDAChol gives rise 
to an increase of CsDAChol fluorescence intensity 
which takes place in the millisecond to second time 
range under conditions of energy transfer from 
proteins. Three major relaxation processes are 
observed, a ‘rapid’ one assigned to the interaction of 
CsDAChol with a state of the AChR with a high 
affinity for agonists, an ‘intermediate’ one accounted 
for by a binding of CsDAChol to AChR sites in a 
state of lower affinity and a ‘slow’ one analysed in 
terms of an interconversion between these low and 
high affinity states of the AChR [ 17,181. In the 
presence of local anesthetics, the amplitude of the 
rapid relaxation process and the rate constant of the 
slow relaxation process increase [ 17,191 : local 
anesthetics stabilize, in an ‘allosteric’ manner, the 
high affinity state of the AChR. 
When the 1% cholate-soluble extract (-0.2 ,uM 
o-toxin binding sites) is rapidly mixed with CsDA- 
Chol (in 1% cholate), an increase of CsDAChol 
fluorescence intensity is also recorded in the milli- 
seconds time range under conditions of energy 
transfer from proteins (tig.2). The signal is abolished 
by preincubation of the soluble extract with saturat- 
ing concentrations of N. nigricollis o-toxin. It is 
therefore associated with the interaction of CSDAChol 
with the AChR-site. At variance with what is observed 
with the native membranes, the traces can be fitted 
in first approximation by a single exponential. 
Figure 3 shows that the amplitude of the fluo- 
rescence signal increases with increasing CsDAChol 
concentration up to a plateau value, and with an 
apparent dissociation constant equal to -1.8 PM. A 
Scatchard plot of the data reveals however a minor 
but significant heterogeneity (see also [ 131) with at 
least two classes of binding sites with app.Kd -1.3 PM 
and -5.3 PM. As shown in fig.4, the k,, of the 
signal increases linearly with increasing CsDAChol 
concentration. 
In first approximation, neglecting this heterogeneity, 
the data can be accounted for by a bimolecular bind- 
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membranes 
diluted extmct 
Fig.2. Single-shot traces of stopped-flow experiments: change 
of fluorescence intensity after rapid mixing in the presence 
and in the absence of 5 mM prilocaine of a solution of 
C,DAChol with (a) native membrane fragments, (b) 1%’ 
cholate-soluble extract, and (c) diluted cholate extract. 
(a) 1 :l mixing of a solution of C,DAChol in Torpedo saline 
solution (-0.4 PM o-toxin binding sites, 0.25 mg protein/ml) 
supplemented or not with 5 mM prilocaine (at least 30 min 
preincubation). (b) The 1% cholatc-soluble extract obtained 
after high speed centrifugation (see section 2) was diluted 
200-fold at a constant cholate concentration, in a Torpedo 
saline solution supplemented with 1% cholate (-0.4 PM 
a-toxin binding sites); 1: 1 mixing with a solution of C,DAChol 
in Torpedo saline solution (same concentration as in (a)) 
supplemented with 1% cholate was done at least 30 min 
later; prilocaine was added as indicated above. (c) The 1% 
cholate-soluble extract obtained after high speed centrifuga- 
tion was diluted 200-fold in Torpedo saline solution (-0.4 PM 
o-toxin binding sites, 0.05% w/v frnal cholate concentration); 
1 :l mixing with a solution of C,DAChol in Torpedo saline 
solution (same concentration as in (a)) supplemented with 
0.05% cholate was done at least 30 min later; prilocaine was 
added as above. 
C$AChoI (t.4) 
Fig.3. Amplitude of the fluorescence intensity increase 
monitored after rapid mixing of native membrane fragments 
(o-o), 1% cholate soluble (o-o) and diluted (A-A) extracts 
with increasing concentration of C,DAChol. Same conditions 
as for fig.2. 
k 
ing reaction R + L $12 RL. Under these conditions 
k-1 
and in the presence of an excess of ligand, kapp = kr 
{L} t k--r and, as observed experimentally, increases 
linearly with ligand concentration. The slope and 
intercept with the ordinate axis are kr = 1.8 X 10’ 
M-r s-l and k.r = 33 s-r. 
With the 1% cholate-soluble extract, local anes- 
thetics such as prilocaine or trimethisoquin no longer 
modify the amplitude and rate constant of the signal 
monitored upon rapid mixing with CsDAChol. At 
-I ./.’ : m - 1m Jr /' . . 5 ./* 
0’ 2 4 6 6 
CSDAChol QM) 
Fig.4. Fluorescence intensity increase monitored after rapid 
mixing of C,DAChol with the 1% cholate-soluble extract: 
plot of the apparent first-order rate constant, k, 
function of the final C,DAChol concentration. 8 
p, ai a 
ame condi- 
tions as for tig.2b; the solid line is a least square fit of the 
data: intercept with the ordinate axis 33 SK’, slope 1.8 X 10’ 
M-r s-l. 
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prilocaine >lO mM, the amplitude of the fluores- 
cence signal decreases without significant change 
of the app. K, for half maximum signal amplitude; 
the kapp values are not modified, which suggests 
that the observed decrease in fluorescence intensity 
is due to a non-specific spectroscopic absorption 
by the local anesthetic rather than to a change in 
the binding properties of the AChR. 
In summary, solubilization by 1% cholate causes a 
marked change in the binding properties of the 
AChR protein which differ from the high affinity 
state present in the native membranes. In addition the 
sensitivity to local anesthetics is lost. 
3.3. Quantitative analysis of the effect of choke on 
the AChR-rich membrane fragments 
Na cholate acts as a dispersive agent at concentra- 
tions close to its critical micellar concentration 
(c.m.c. -0.65% w/v). At lower concentrations 
(i.e. -lOO-fold below the c.m.c.) it blocks in vivo 
the response of the electroplaque to agonists in a 
non-competitive manner and behaves in this respect 
like a local anesthetic [ 14,251. An important ques- 
tion is whether or not this last effect accounts, at 
least in part, for the particular properties of the 
receptor protein in 1% cholate. To answer this ques- 
tion, the effect of cholate on the AChR-rich mem- 
brane fragments was quantitatively studied as a 
function of cholate concentration. Membrane 
fragments were preincubated with cholate from 
0.001-l% (w/v), and thereafter mixed in the 
stopped-flow apparatus with a solution of 2 PM 
CsDAChol supplemented with the corresponding 
concentration of cholate (in order to keep the cholate 
concentration constant). In these conditions, the 
fluorescence signal obtained resembles that found 
with typical local anesthetics [ 17,191. The amplitude 
of the rapid relaxation process increases up to a 
plateau value which represents -65% of the total 
signal amplitude (fig.5) with, for this effect, an app. 
K, -0.06% w/v (-1.4 mM). At higher concentrations 
and upon increasing cholate concentration from 
OS-l%, a marked qualitative change of the fluo- 
rescence signal is observed. The traces which can be 
decomposed into three distinct processes for a 
concentration of cholate smaller than the c.m.c. 
(i.e. up to 0.5% cholate) become monophasic in the 
presence of 1% cholate as in the case of the soluble 
EFFECTOR (M) 
Fig.5. Effect of local anesthetics and cholate on the relative 
amplitude of the rapid relaxation process monitored with the 
native membrane fragments (open symbols) and the diluted 
cholate extract (ffiled symbols). The amplitudes of the rapid 
relaxation process are given as % of the total amplitude of the 
fluorescence signal (which is not modified by the presence of 
local anesthetics in the domain of concentration studied) for 
cholate (o-o), prilocaine, (o-o; 0-o) and trimethisoquin 
(a-*; A-A). Same experimental conditions as for tig.2c 
(o-o; A-A). Data from [ 191 (o-o; &-A). Same experimental 
conditions as for fig2a (n-o). 
extract in the previous experiments. Conversely, the 
rate constant of the monophasic signal recorded in 
the presence of 1% cholate becomes -2-times slower 
than the rapid relaxation process monitored in the 
presence of 0.5% cholate and cannot be related to 
any of the two other (slow and intermediate) relaxa- 
tion processes. In other words, when the concentra- 
tion of cholate increases from 0.5-l% the kinetic and 
binding properties of the AChR-protein follow a 
discontinuous and sharp transition which cannot be 
assigned to a local anesthetic effect of cholate but 
rather to a change in the environment of the receptor 
protein. 
3.4. Recovery of the binding properties of the 
AChR-protein after removal of cholate by dilution 
In an attempt to recover the properties of the 
membrane-bound AChR the concentration of cholate 
in the soluble extract was reduced by dilution to a 
final concentration of 0.05% w/v, below the critical 
micellar concentration (0.65% w/v cholate). The 
diluted extract (-0.2 /.JM a-toxin sites, 0.05% cholate) 
was then rapidly mixed in the stopped-flow apparatus 
with various concentrations of CsDAChol in Torpedo 
saline solution (supplemented with 0.05% cholate). 
Under these conditions a change of fluorescence 
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intensity is recorded (“ig.2) which, again, is abolished 
by preincubation with saturating concentrations of 
.N. nigricollis cu-toxin. The amplitude of the fluo- 
rescence signal increases with increasing CsDAChol 
concentrations (fig.3). A plot on a linear scale of the 
amplitude as a function of C5DAChol concentration 
resembles a titration curve with a linear increase of 
the amplitude, up to a plateau value at cont. >0.2 nM 
(the concentration in o-toxin binding sites). The mid- 
point of the curve takes place at CsDAChol -0.1 PM, 
which is approximately one order of magnitude 
smaller than the corresponding value measured in the 
case of the 1% cholate extract but still is an over- 
estimate of the microscopic equilibrium dissociation 
constant. 
At variance with what is observed with the 1% 
cholate-soluble extract, the traces are no longer 
monophasic but display, for given CsDAChol concen- 
trations, the three relaxation processes characteristic 
of the native membrane fragments [ 17-191 . More- 
over, the rate constants of the three processes and 
their dependence with CsDAChol concentration 
appear very similar to those found with the native 
membranes (fig.6). 
The data can be accounted for by the same two- 
state model as that used to fit the results given by 
Fig.6. Plot of the k values of the rapid (a), intermediate 
(b) and slow (c) rela%%on process as a function of C,DAChol 
concentration, for the AChR-rich membrane fragment? (9-o) 
and the diluted cholate extract (0-0). Same experimental 
conditions as for fig.2 (a,c). 
the AChR-rich membranes [18,19] . The model 
postulates, in particular, the interconversion of the 
AChR between two confomrational states with a low 
(-1 /JM) and high (-3 nM) affinity of the ACh binding 
site for CsDAChol. Only minor differences were 
noticed between the diluted extract and the native 
membranes: a slightly higher rate constant of the 
slow relaxation process and a larger amplitude of the 
rapid relaxation process. With the diluted cholate 
extract, this last amplitude represents as much as 
-50% of the total amplitude of the fluorescence 
intensity change, against only 20% in the case of the 
native membrane fragments. In other words, the 
fraction of high affinity sites present spontaneously 
in the cholate-diluted extract is larger than in the 
native membranes. 
Interestingly, dilution of the cholate extract leads 
to a recovery of the sensitivity to local anesthetics 
which, in many instances, appears similar to that of 
the membrane-bound AChR. In the presence of two 
typical local anesthetics uch as prilocaine and tri- 
-rethisoquin, the amplitude of the rapid relaxation 
recess increases, without change in the total ampli- 
tude of the fluorescence signal recorded after complete 
equilibration (fig.5). The effect takes place in a 
domain of concentration similar to that observed 
with the native membrane fragments, with app. 
Kd = 1.5 mM for prilocaine and 7 PM for trimethiso- 
quin (versus 1.5 mM and 10 PM, respectively, for 
native membrane fragments). Furthermore, and in 
agreement with what is observed with native mem- 
brane fragments, the rate constants of the intermediate 
and slow relaxation processes increase, whereas that of 
the rapid relaxation process slightly decreases. In 
both cases, the data can be interpreted in terms of a 
stabilisation of the high affinity state of the AChR by 
local anesthetics. 
Upon removal of the detergent, the AChR there- 
fore regains equilibrium binding properties, confor- 
mational transition kinetics and sensitivity to local 
anesthetics almost identical to those measured with 
the native membrane fragments. 
Recovery after cholate dilution occurs rapidly. No 
difference was detected in the traces recorded 2 min 
(which is the shortest time needed for dilution and 
introduction of the solution in the stopped-flow 
syringes) and several hours after dilution. Time- 
dependent effects, however, were noticed at the level 
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of the solubilization process. Prolonged storage of the 
concentrated (5%) cholate extract leads to a decrease 
of the fluorescence signal monitored after dilution of 
the cholate extract, which cannot be accounted for 
by a change in the binding properties of the AChR 
but rather by an irreversible decrease in the number 
of binding sites (50% decrease after 45 min and 
almost 100% after 3 h). On the other hand, no sig- 
nificant time-dependent effect is observed upon 
storage in 1% or, a fortiori, 0.05% cholate. 
After cholate dilution, the AChR-protein followed 
by 01- [3H] toxin binding is no longer in a soluble form 
and can be sedimented by centrifugation at 
100 000 X g. Polyacrylamide gel electrophoresis of 
the pellet in the presence of sodium dodecyl sulfate 
yields both the mol. wt 40 000 and 43 000 bands. 
In other words, the dilution of the cholate extract 
which results in the recovery of the most characteristic 
properties of the membrane-bound AChR also causes 
an aggregation of the two major protein components 
of the AChR-rich membranes. 
4. Conclusion 
Upon solubilization of the AChR-rich membrane 
fragments by cholate a marked change in the binding 
properties of the AChR-protein takes place. In 
particular, and in agreement with previous work, the 
sensitivity to local anesthetics is lost. In other words, 
the binding sites for ACh and for local anesthetic are 
phenomenologically uncoupled. 
At least three explanations for this effect are 
possible: 
1. The local anesthetic binding site itself is occupied 
or hidden by the detergent which therefore inter- 
feres directly with the binding of local anesthetics 
to their proper site of action. 
2. The coupling between the local anesthetic and the 
ACh binding sites is lost upon detergent solubiliza- 
tion as a consequence of a physical uncoupling of 
the protein units which carry the two classes of 
sites. 
3. In the presence of detergent the AChR is ‘frozen’ 
in one (or multiple) affinity state which excludes 
conformational transitions between affinity states. 
The first hypothesis is plausible, but appears unlikely 
since cholate acting as a local anesthetic should 
stabilize the membrane-bound AChRin a high affinity 
state which is clearly distinct from the low affinity 
state found in the cholate-soluble extract. Hypotheses 
2 and 3 are not mutually exclusive and could account 
for the effect. Recent progress in the identification of 
the major polypeptide chains present in the highly 
purified membrane fragments suggest hat the local 
anesthetic binding site could be carried by the 43 k 
protein, distinct from the 9 S soluble macromolecule 
identified as the AChR protein. These two proteins 
are still present in the 1% cholate extract, but are no 
longer physically coupled. 
When the concentration of the detergent is lowered 
by dilution, the binding properties of the AChR and 
the sensitivity to local anesthetics become very close 
to those found with the native membrane fragments. 
Only minor differences are noticed. For instance, the 
fraction of AChR sites in a high affinity state before 
the addition of CsDAChol, and the rate constant of 
the slow relaxation process are higher with the diluted 
cholate extract than with the native membrane frag- 
ments. At least two interpretations may account for 
these observations: 
1. The intrinsic properties of the AChR are strictly 
identical before and after solubilization, but traces 
amount of cholate are still present after dilution 
and change both the equilibrium and dynamic 
properties of the AChR. As mentioned in section 
3, cholate indeed exerts a local anesthetic action 
in vivo, and modifies in vitro the kinetics of the 
interaction of CsDAChol with the membrane- 
bound AChR in the expected direction. 
2. The solubilization process, the centrifugation and 
the final dilution alter the binding properties of the 
AChR as a consequence possibly of a change in the 
lipid environment and/or incomplete reconstitu- 
tion. 
In any case, the main features of the allosteric 
interaction between AChR-site and local anesthetic 
binding site can be ‘reconstituted’ after elimination 
of the detergent from a crude extract of subsynaptic 
membrane fragments. Under these conditions, AChR 
and 43 k protein aggregate into high molecular weight 
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particles. This method can therefore be used to test 
the functional significance of the 43 k protein. 
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